NCAM2 and Alzheimer disease: (42) found that the levels of synaptic NCAM2 were significantly reduced, whereas levels of soluble fragment of NCAM2 were increased in the hippocampus of AD brains compared with controls, indicating an increased proteolysis of NCAM2.